Xconomy
MAY 24, 2018
Bloom Science , a biotech founded to advance a new class of microbe-based therapeutics for neurological disorders, is making its debut today with the publication of research that suggests certain bacteria in the gut could be used to manage epileptic seizures.
Both Sides of the Table
FEBRUARY 20, 2012
Sam is the managing director of Launchpad LA and we were about to pick our 2012 class of entrepreneurs. Tracy is knowledgeable enough to talk tech and swap design & product stories with other founders, but she realized early that networking amongst this group and reading and writing in their journals would not bring her more customers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
SEPTEMBER 6, 2019
If MedCo’s cholesterol-lowering drug inclisiran wins FDA approval, it will become the third entry in a new class of medicines that block a cholesterol-boosting protein called PCSK9. But the first mover isn’t infallible if someone else has something better. That’s something the The Medicines Co. is counting on.
Tech Zulu Event
OCTOBER 8, 2013
In June, The Wall Street Journal profiled McClure and 500 Startups’ unique model. ” According to the 500 Startups blog, 130 companies were interviewed for the spots in the upcoming fall program that include MailLift. ” said Joe Kirgues, co-founder of the accelerator MailLift went through prior to 500 Startups.
Xconomy
AUGUST 19, 2016
Meanwhile, the latest study reporting that the drugs’ $14,000-a-year list price isn’t cost effective, published this week in the Journal of the American Medical Association , has the drugs’ owners, Amgen (NASDAQ: AMGN ) and Regeneron Pharmaceuticals (NASDAQ: REGN ), up in arms.
SoCal Delicious
OCTOBER 8, 2012
Professor Journal. Student Journal. Developments Blog. Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). edition of The Wall Street Journal, with the headline: Tech Titans Hit the Beach. Journal Community. MarketWatch. MarketWatch. AllThingsDigital. Financial News.
Both Sides of the Table
NOVEMBER 22, 2014
But this is a high-class problem they solve for me. It has bordered on obsessive from one journal more than others and it’s somewhat hard to attack a company for smear tactics with, well, smear tactics. Case in point, “ Why Your Uber Driver Hates Uber ” is a blog post dressed up as journalism.
Expert insights. Personalized for you.
76 
Let's personalize your content